After starting on a weak note, the ASX climbed this afternoon to end the day 0.57% higher, reaching a fresh four-week high.
The Property sector was the standout, up 1.55%, with Goodman Group (ASX:GMG) up 3.49% and Charter Hall gaining 2.45%.
The Consumer Discretionary sector was also strong, led by an upbeat outlook from Harvey Norman that saw the retailer gain 4.43% over the session. While HVN reported lower sales and earnings for the half year, executive chairman Gerry Harvey said the company was well-placed for a rebound in the building cycle.
Utilities was the only sector to end the day in the red.
Star Entertainment ended up 7.29% despite a 14% fall in revenue as it faces licence problems in Sydney. Despite the fall in revenue, the casino operator swung to a net profit of $9.1 million.
ASX Wolf bankrupt
Social media influencer Tyson Scholz, known as the 'ASX Wolf', has been bankrupted by the Australian Securities and Investments Commission (ASIC)
The bankruptcy was declared in the Federal Court earlier this month after Scholz was ordered to pay $456,296 in costs relating to earlier civil action against him by ASIC for carrying on a financial services business without an Australian financial services licence.
Scholz made more than $1 million by promoting shares online and charging subscribers between $500-$1,500 for share trading courses
ASIC today said that Scholz had not paid the court-ordered costs, so had sought bankruptcy action against him.
Five at five
Cooper Metals follows up “spectacular hits” with diamond drilling at Brumby Ridge copper-gold prospect
Cooper Metals Ltd (ASX:CPM) has kicked off diamond drilling at the Brumby Ridge copper-gold prospect at the Mt Isa East Copper-Gold Project in northwest Queensland, following up on last year’s drill hits described as "spectacular".
Magnetite Mines reveals plans to partner with South Australian Government on 'green iron vision'
Magnetite Mines Ltd (ASX:MGT) is aligned with the South Australian Government's initiative to pioneer a local green iron and steel industry.
Radiopharm Theranostics doses first patient in Phase 1 pancreatic imaging study of RAD 301
Radiopharm Theranostics Ltd (ASX:RAD, OTC:RDPTF) has officially begun dosing patients for a Phase 1 clinical study assessing the diagnostic potential of radiopharmaceutical 68Ga-Trivehexin (RAD 301) targeting the αvβ6 integrin, for the detection of lesions in patients with Pancreatic Ductal Adenocarcinoma (PDAC).
Emyria delivers more than $2 million in clinical billings in the past half-year
Emyria Ltd (ASX:EMD), a mental health and neurologically focused biotechnology company developing a cutting-edge MDMA-assisted therapy model, has had a busy half year.
Alkane Resources on the cusp of potential expansion: RaaS Advisory
Alkane Resources Ltd (ASX:ALK, OTC:ALKEF) is making strong progress at its Northern Molong Porphyry Project in New South Wales which includes the highly prospective Boda and Kaiser deposits, according to RaaS Advisory.
On your six
Chinese-Australian businessman jailed over efforts to influence former federal MP
In a first for Australian law, Melbourne businessman and former Victorian state Liberal candidate Di Sanh Duong has been found guilty under Australian foreign interference laws and sentenced to at least 12 months in jail.
One to watch
Aura Energy releases positive FEED study at Tiris
Newly appointed Aura Energy Ltd (ASX:AEE, AIM:AURA) CEO Andrew Grove joins Jonathan Jackson in the Proactive studio to discuss the company’s uranium ambitions and its work at the Tiris Uranium Project in Mauritania